Myriad Genetics Inc $37.70

down 0.00


9/7/2014 04:00 PM  |  NASDAQ : MYGN  
Industries : Diversified Services / Research Services
Get Trend Analysis Icon Get MYGN Trend Analysis - it has outperformed the S&P 500 by 7%

Partner Headlines

  1. Albany Molecular's Oso Buy Seen Boosting Earnings

    IBD
  2. Novo, Other Medicals Display Healthy Action

    IBD
  3. A Few Medical Research Stocks Break Out, Others Basing

    IBD
  4. MYRIAD GENETICS

    IBD
  5. Quiet Session Intensifies As Stocks Hit Session Lows

    IBD
  6. Stocks Extend Losses; AerCap Hits High On Earnings

    IBD
  7. Myriad Genetics and UnitedHealthcare Sign 3 Yr Deal To Make Cancer Tests ...

    Benzinga
  8. Earnings Scheduled For May 6, 2014

    Benzinga
  9. Ubiquiti, Avis Budget Among 5 IBD 50 Stocks Reporting

    IBD
  10. Why I Bought Myriad Genetics (MYGN)

    GuruFocus
  11. Top 4 NASDAQ Stocks In The Research Services Industry With The Highest ...

    Benzinga
  12. Myriad Genetics Is Saving Lives With New Products

    IBD
  13. Analyst Bullish On Medical Research, Equipment Stocks

    IBD
  14. Myriad, Tata Motors Among RS Leaders In Correction

    IBD
  15. UPDATE: Myriad Genetics Submits Premarket Approval to FDA for BRACAnalysis(R)

    Benzinga
  16. Avis Budget Leads 5 IBD 50 Stocks Holding Up Well

    IBD
  17. Stocks Jump, Then Trim Gains; Anadarko, Align Rock Ahead

    IBD
  18. Myriad soars to a 5-year high

    IBD
  19. Myriad Gaps Up To High On Reimbursement Rate Change

    IBD
  20. Indexes Extend Win Streak As S&P 500 Marks New High

    IBD
  21. Mid-Afternoon Market Update: MannKind Hangs Onto its Gains as Yelp Shares ...

    Benzinga
  22. Indexes Hold Modest Gains; Under Armour On The Move

    IBD
  23. Mid-Day Market Update: Apollo Drops After Q2 Results; MannKind Shares Spike ...

    Benzinga
  24. Indexes Edge Higher; Rubicon Project Soars In Debut

    IBD
  25. Myriad Genetics Soars On CMS Reimbursement Increase

    IBD
  26. Mid-Morning Market Update: Markets Flat; Monsanto Earnings Beat Street ...

    Benzinga
  27. Benzinga's Volume Movers

    Benzinga
  28. Stocks Whittle Opening Gains; Apollo Tumbles, Despite Upgrade

    IBD
  29. Morning Market Movers

    Benzinga
  30. Jobs Data Trim Stock Futures; Myriad Genetics Spikes

    IBD
  31. J.P. Morgan Reinstates Underweight Rating on Myriad Over LT Outlook Concerns

    Benzinga
  32. Top 4 Stocks In The Research Services Industry With The Lowest PEG Ratio

    Benzinga
  33. Myriad falls on rival product

    IBD
  34. General Motors, Tesla Motors Under Late Pressure

    IBD
  35. Stocks Worsen In Late Trade; Ubiquiti Gains

    IBD
  36. Mid-Day Market Update: Men's Wearhouse To Acquire Jos. A. Bank For $65/Share; ...

    Benzinga
  37. Market Rallies; Green Mountain Changes Its Name

    IBD
  38. Mid Morning Losers for March 11th, 2014

    Benzinga
  39. Myriad Stock Tumbles After Court Allows Rival To Sell

    IBD
  40. Mid-Morning Market Update: Markets Edge Lower; American Eagle Issues Weak ...

    Benzinga
  41. Morning Market Losers

    Benzinga
  42. Stocks Futures Effectively Flat; Boyd Gaming Up, Myriad Dives

    IBD
  43. Benzinga's Top #PreMarket Losers

    Benzinga
  44. Medical Research Providers Ride Higher With Biotechs

    IBD
  45. Investing Like Martin Zweig: Growth With A Conservative Streak

    Benzinga
  46. US Stock Futures Up; All Eyes On Jobs Report

    Benzinga
  47. Mid-Afternoon Market Update: Sprint Rises on News it Has the Financing ...

    Benzinga
  48. Mid-Day Market Update: CH Robinson Shares Drop On Downbeat Results; Tableau ...

    Benzinga
  49. Mid-Morning Market Update: Markets Open Lower; Time Warner Earnings Beat ...

    Benzinga
  50. Stock Futures Under Pressure; CVS Caremark Dips, Myriad Jumps

    IBD
Trading Center